Envveno Medical Corp key statistics and ratios

In fiscal 2019, Envveno Medical Corp had a net margin of -24406.7%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Envveno Medical Corp: financial ratios, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019
Net margin	<−999%	<−999%	<−999%
Return on assets	−351.8%	−451.7%	−218.1%
R&D as % of revenue	153.9%	664.0%	>999%
SG&A as % of revenue	>999%	>999%	>999%

US$ thousands unless shown otherwise. Fiscal quarters.

Envveno Medical Corp: financial ratios, quarterly
Quarter	2018 Q1Mar 2018	2018 Q2Jun 2018	2018 Q3Sept 2018	2018 Q4Dec 2018	2019 Q1Mar 2019	2019 Q2Jun 2019	2019 Q3Sept 2019	2019 Q4Dec 2019
Net margin	<−999%	<−999%	<−999%	<−999%	<−999%	—	—	—
R&D as % of revenue	774.2%	336.4%	>999%	962.6%	>999%	—	—	—
SG&A as % of revenue	>999%	>999%	>999%	>999%	>999%	—	—	—

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Envveno Medical Corp's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Envveno Medical Corp.